Stryker Management Trio Poised To Restore 20% Earnings Growth By 2000
This article was originally published in The Gray Sheet
Executive Summary
Stryker's ability to successfully integrate Howmedica and return to historical earnings growth (20% annually the past two decades) by 2000 rests largely in the hands of three recently appointed Group Presidents - Ronald A. Elenbaas (Med-Surg), Edward "Ned" Lipes (Howmedica Osteonics U.S.) and Jack O'Mahony (Stryker International).
You may also be interested in...
Stryker Blade Recall To Be Complete By September; OP-1 PMA Filed By FDA
Stryker Instruments anticipates retrieving within 30 days certain lots of Heavy Duty blades recalled because of a "slight potential" for package failure that could affect the sterility of the devices.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.